Trial Profile
A multicenter, cohort study to evaluate the the efficacy of Vedolizumab in patients with inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Oct 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 22 Oct 2016 New trial record